Literature DB >> 35264728

Neurocan regulates vulnerability to stress and the anti-depressant effect of ketamine in adolescent rats.

Zhoulong Yu1, Ying Han1, Die Hu1, Na Chen1, Zhongyu Zhang1, Wenxi Chen1, Yanxue Xue1, Shiqiu Meng1, Lin Lu1,2,3, Wen Zhang4, Jie Shi5.   

Abstract

Depression is more prevalent among adolescents than adults, but the underlying mechanisms remain largely unknown. Using a subthreshold chronic stress model, here we show that developmentally regulated expressions of the perineuronal nets (PNNs), and one of the components, Neurocan in the prelimbic cortex (PrL) are important for the vulnerability to stress and depressive-like behaviors in both adolescent and adult rats. Reduction of PNNs or Neurocan with pharmacological or viral methods to mimic the expression of PNNs in the PrL during adolescence compromised resilience to stress in adult rats, while virally mediated overexpression of Neurocan reversed vulnerability to stress in adolescent rats. Ketamine, a recent-approved drug for treatment-resistant depression rescued impaired function of Parvalbumin-positive neurons function, increased expression of PNNs in the PrL, and reversed depressive-like behaviors in adolescent rats. Furthermore, we show that Neurocan mediates the anti-depressant effect of ketamine, virally mediated reduction of Neurocan in the PrL abolished the anti-depressant effect of ketamine in adolescent rats. Our findings show an important role of Neurocan in depression in adolescence, and suggest a novel mechanism for the anti-depressant effect of ketamine.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35264728     DOI: 10.1038/s41380-022-01495-w

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   13.437


  72 in total

Review 1.  Mood disorders in children and adolescents: an epidemiologic perspective.

Authors:  R C Kessler; S Avenevoli; K Ries Merikangas
Journal:  Biol Psychiatry       Date:  2001-06-15       Impact factor: 13.382

2.  Concurrent overproduction of synapses in diverse regions of the primate cerebral cortex.

Authors:  P Rakic; J P Bourgeois; M F Eckenhoff; N Zecevic; P S Goldman-Rakic
Journal:  Science       Date:  1986-04-11       Impact factor: 47.728

3.  Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication--Adolescent Supplement (NCS-A).

Authors:  Kathleen Ries Merikangas; Jian-Ping He; Marcy Burstein; Sonja A Swanson; Shelli Avenevoli; Lihong Cui; Corina Benjet; Katholiki Georgiades; Joel Swendsen
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-07-31       Impact factor: 8.829

Review 4.  New insights into the classification and nomenclature of cortical GABAergic interneurons.

Authors:  Javier DeFelipe; Pedro L López-Cruz; Ruth Benavides-Piccione; Concha Bielza; Pedro Larrañaga; Stewart Anderson; Andreas Burkhalter; Bruno Cauli; Alfonso Fairén; Dirk Feldmeyer; Gord Fishell; David Fitzpatrick; Tamás F Freund; Guillermo González-Burgos; Shaul Hestrin; Sean Hill; Patrick R Hof; Josh Huang; Edward G Jones; Yasuo Kawaguchi; Zoltán Kisvárday; Yoshiyuki Kubota; David A Lewis; Oscar Marín; Henry Markram; Chris J McBain; Hanno S Meyer; Hannah Monyer; Sacha B Nelson; Kathleen Rockland; Jean Rossier; John L R Rubenstein; Bernardo Rudy; Massimo Scanziani; Gordon M Shepherd; Chet C Sherwood; Jochen F Staiger; Gábor Tamás; Alex Thomson; Yun Wang; Rafael Yuste; Giorgio A Ascoli
Journal:  Nat Rev Neurosci       Date:  2013-02-06       Impact factor: 34.870

5.  National Trends in the Prevalence and Treatment of Depression in Adolescents and Young Adults.

Authors:  Ramin Mojtabai; Mark Olfson; Beth Han
Journal:  Pediatrics       Date:  2016-11-14       Impact factor: 7.124

6.  Evidence for a neuroinflammatory mechanism in delayed effects of early life adversity in rats: relationship to cortical NMDA receptor expression.

Authors:  Andrea Wieck; Susan L Andersen; Heather C Brenhouse
Journal:  Brain Behav Immun       Date:  2012-12-01       Impact factor: 7.217

7.  Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants.

Authors:  Ronald S Duman; George K Aghajanian; Gerard Sanacora; John H Krystal
Journal:  Nat Med       Date:  2016-03       Impact factor: 53.440

8.  Brain-derived neurotrophic factor signaling and subgenual anterior cingulate cortex dysfunction in major depressive disorder.

Authors:  Adam Tripp; Hyunjung Oh; Jean-Philippe Guilloux; Keri Martinowich; David A Lewis; Etienne Sibille
Journal:  Am J Psychiatry       Date:  2012-11       Impact factor: 18.112

9.  Protracted developmental trajectories of GABAA receptor alpha1 and alpha2 subunit expression in primate prefrontal cortex.

Authors:  Takanori Hashimoto; Quyen L Nguyen; Diana Rotaru; Tanya Keenan; Dominique Arion; Monica Beneyto; Guillermo Gonzalez-Burgos; David A Lewis
Journal:  Biol Psychiatry       Date:  2009-02-27       Impact factor: 13.382

Review 10.  Why do many psychiatric disorders emerge during adolescence?

Authors:  Tomás Paus; Matcheri Keshavan; Jay N Giedd
Journal:  Nat Rev Neurosci       Date:  2008-11-12       Impact factor: 34.870

View more
  3 in total

Review 1.  Effects of chronic fluoxetine treatment on anxiety- and depressive-like behaviors in adolescent rodents - systematic review and meta-analysis.

Authors:  Joanna Kryst; Iwona Majcher-Maślanka; Agnieszka Chocyk
Journal:  Pharmacol Rep       Date:  2022-09-24       Impact factor: 3.919

2.  Impact of stress on inhibitory neuronal circuits, our tribute to Bruce McEwen.

Authors:  Marta Perez-Rando; Hector Carceller; Esther Castillo-Gomez; Clara Bueno-Fernandez; Clara García-Mompó; Javier Gilabert-Juan; Ramón Guirado; Ana Paula Pesarico; Juan Nacher
Journal:  Neurobiol Stress       Date:  2022-05-13

3.  Effects of 3-methylmethcathinone on conditioned place preference and anxiety-like behavior: Comparison with methamphetamine.

Authors:  Yang Chen; Libo Zhang; Zengbo Ding; Xianwen Wu; Guibin Wang; Jie Shi
Journal:  Front Mol Neurosci       Date:  2022-07-22       Impact factor: 6.261

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.